Showing 3941-3950 of 23227 results for "".
Timely ATTR-CM Diagnosis: Addressing Social Determinants of Health
https://reachmd.com/programs/heart-matters/timely-attr-cm-diagnosis-addressing-social-determinants-of-health/36141/Understanding the impact of social determinants of health on transthyretin amyloid cardiomyopathy (ATTR-CM) diagnosis is essential to improving patient outcomes. Hear Dr. Kevin Alexander, an Assistant Professor of Medicine at Stanford University School of Medicine, break down how factors like povertNectin-4-Directed ADCs in Bladder Cancer
https://reachmd.com/programs/cme/nectin-4-directed-adcs-in-bladder-cancer/13890/Rapid-fire approvals of ADCs for a variety of solid tumors now present a clinical conundrum when managing adverse events. Brush up on your knowledge!Managing the Side Effects of ADHD Medications
https://reachmd.com/programs/updates-from-mayo-clinic/managing-the-side-effects-of-adhd-medications/6786/Host Dr. Peter Jensen welcomes Dr. Martin Stein, Professor of Pediatrics at the University of California, San Diego, and Rady Children's Hospital, San Diego. Dr. Stein's academic interest has been the development of methods to incorporate concepts about child development and behavioral pediatrics inGenetic Testing Among Women with Breast Cancer Increasing, Can Impact Treatment Decisions
https://reachmd.com/programs/the-jama-report/genetic-testing-among-women-breast-cancer-increasing-can-impact-treatment-decisions/7935/[Read the Article] Rates of genetic testing for BRCA1 and BRCA2 mutations have increased among younger women diagnosed with breast cancer, according to a new study. The study focused on nearly 900 women diagnosed with breast cancer at age 40 or younger. Researchers looked at rates of genetic testingAddressing Health Equity in Genitourinary Cancer Clinical Trials
https://reachmd.com/programs/project-oncology/addressing-health-equity-in-genitourinary-cancer-clinical-trials/16288/Can addressing the health equity gaps in GU cancer clinical trials help to advance patient care? Dive in.Improving Adherence to Topical Regimens
https://reachmd.com/programs/dermatology-hub-neuroimmune-network/improving-adherence-to-topical-regimens/48780/Zoe Diana Draelos, MD, discusses strategies for improving adherence to topical regimens in chronic atopic dermatitis.Learning, Laughing, and Living with Multiple Sclerosis
https://reachmd.com/diseases-diagnoses/ms-immune-disorders/learning-laughing-and-living-with-multiple-sclerosis/37228/Ardra Shephard, a musician, author, fashion-show TV host, podcaster, and MS advocate, discusses her experiences living with MS, including how she uses her story to educate and encourage others living with MS. She is joined by Jiwon Oh, MD, Medical Director of the Barlo Multiple Sclerosis Program atRebalancing Amyloid in ATTR-CM: Emerging Therapeutic Insights
https://reachmd.com/programs/Audioabstracts/rebalancing-amyloid-attr-cm/49065/While transthyretin amyloid cardiomyopathy (ATTR-CM) is often viewed solely as a disorder of protein misfolding, a new review published in the European Heart Journal presents it as a dynamic imbalance between amyloid production and clearance. Hear from Dr. Hallie Blevins as she reviews pivotal dataOptimizing Generalized Myasthenia Gravis Care Through Patient-Centered Choices
https://reachmd.com/programs/neurofrontiers/optimizing-generalized-myasthenia-gravis-care-through-patient-centered-choices/32860/Choosing the most appropriate treatment for generalized myasthenia gravis (gMG) involves more than managing visible symptoms. Many patients adapt to their limitations, making it essential to use structured tools that reveal the true impact on their daily life. Hear Dr. Sheetal Shroff, who spoke withTriglycerides and Residual Risk in Secondary Cardiovascular Prevention: Lessons From UCC-SMART
https://reachmd.com/programs/heart-matters/triglycerides-and-residual-risk-in-secondary-cardiovascular-prevention-lessons-from-ucc-smart/37596/Even with LDL cholesterol under control, cardiovascular risk often remains. In this AudioAbstract, ReachMD's Ryan Quigley shares new insights from the UCC-SMART cohort, including how elevated triglycerides can independently predict recurrent events and mortality in patients with established cardiova